Picture of Humana logo

HUM — Humana News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

India's Glenmark quarterly profit falls on lower North America sales

India's Glenmark quarterly profit falls on lower North America sales

- India's Glenmark Pharmaceuticals GLEN.NS posted a 56.8% drop in second-quarter profit on Thursday, weighed down by lower revenue from its North American business.

The company reported a consolidated net profit of 2.64 billion rupees ($27.93 million) for the quarter ended September 30, compared with 6.10 billion rupees a year ago.

  • Total revenue for the quarter declined about 30% to 42.47 billion rupees

  • Glenmark's North America revenue fell to $126.6 million, from $516.7 million a year earlier. Excluding deferred out-licensing income recognition for oncology treatment ISB 2001, the region's core business grew about 31%, it said

  • Consolidated profit before exceptional items and tax fell to 6.22 billion rupees, from 23.53 billion rupees a year ago

  • The company and its US unit agreed to a $15.28 million settlement with US health insurer Humana HUM.N. Along with legal costs, one-time regulatory and other costs, it made up exceptional items of 2.84 billion rupees for the quarter

  • Cost of materials consumed rose 16%, though total expenses fell about 7%

($1 = 94.5075 Indian rupees)


(Reporting by Saikeerthi and Anushka Rajvedi in Bengaluru; Editing by Abinaya V and Shilpi Majumdar)

((Saikeerthi@thomsonreuters.com;))

Recent news on Humana

See all news